Citadel Advisors
BCLI

Citadel Advisors’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Hold
0
5982
2024
Q3
Hold
0
5818
2024
Q2
Hold
0
5918
2024
Q1
Hold
0
6117
2023
Q4
Hold
0
5905
2023
Q3
Sell
-40,956
Closed -$84.4K 5879
2023
Q2
$84.4K Buy
40,956
+27,788
+211% +$57.2K ﹤0.01% 4824
2023
Q1
$43.5K Sell
13,168
-3,296
-20% -$10.9K ﹤0.01% 5210
2022
Q4
$27K Sell
16,464
-14,543
-47% -$23.8K ﹤0.01% 5478
2022
Q3
$137K Buy
31,007
+5,322
+21% +$23.5K ﹤0.01% 5003
2022
Q2
$70K Buy
25,685
+1,566
+6% +$4.25K ﹤0.01% 5409
2022
Q1
$81K Buy
+24,119
New +$81K ﹤0.01% 5741
2021
Q4
Sell
-16,480
Closed -$54K 6459
2021
Q3
$54K Sell
16,480
-34,687
-68% -$114K ﹤0.01% 6095
2021
Q2
$195K Buy
51,167
+11,613
+29% +$44.2K ﹤0.01% 5596
2021
Q1
$151K Buy
+39,554
New +$151K ﹤0.01% 5593
2020
Q4
Hold
0
5061
2020
Q3
Hold
0
4667
2020
Q2
Hold
0
4634
2020
Q1
Sell
-12,240
Closed -$52K 4832
2019
Q4
$52K Buy
+12,240
New +$52K ﹤0.01% 4383
2019
Q3
Sell
-16,814
Closed -$66K 4664
2019
Q2
$66K Buy
16,814
+2,903
+21% +$11.4K ﹤0.01% 4319
2019
Q1
$60K Buy
13,911
+3,044
+28% +$13.1K ﹤0.01% 4189
2018
Q4
$39K Buy
+10,867
New +$39K ﹤0.01% 4140
2018
Q3
Hold
0
4276
2018
Q2
Hold
0
4166
2018
Q1
Sell
-15,034
Closed -$59K 3974
2017
Q4
$59K Buy
15,034
+236
+2% +$883 ﹤0.01% 3598
2017
Q3
$61K Buy
+14,798
New +$61K ﹤0.01% 3391
2017
Q2
Sell
-17,372
Closed -$74K 3646
2017
Q1
$74K Buy
+17,372
New +$74K ﹤0.01% 3360
2016
Q2
Sell
-11,948
Closed -$32K 3365
2016
Q1
$32K Buy
+11,948
New +$32K ﹤0.01% 3072